IL-17A is not expressed by CD207+ cells in Langerhans Cell Histiocytosis lesions

di Allen, Carl E, McClain, Kenneth L
Pubblicazione 2009

fHLH: becoming a blended family

di Allen, Carl E., McClain, Kenneth L.
Pubblicazione 2014

Treatment of LCH: It is time to learn from the past: Response to Minkov and Rodriguez-Galindo

di Allen, Carl E., McClain, Kenneth L.
Pubblicato in Br J Haematol (2015)

Pathological Consequence of Misguided Dendritic Cell Differentiation in Histiocytic Diseases

di Berres, Marie-Luise, Allen, Carl E., Merad, Miriam
Pubblicazione 2013

Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?

di Berres, Marie-Luise, Merad, Miriam, Allen, Carl E.
Pubblicato in Br J Haematol (2014)

The κB transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study

di Allen, Carl E, Mak, Chi-ho, Wu, Lai-Chu
Pubblicazione 2002

Inhibition of NF-κB by ZAS3, a zinc-finger protein that also binds to the κB motif

di Hong, Joung-Woo, Allen, Carl E., Wu, Lai-Chu
Pubblicazione 2003

Pediatric Lymphomas and Histiocytic Disorders of Childhood

di Allen, Carl E., Kelly, Kara M., Bollard, Catherine M.
Pubblicato in Pediatr Clin North Am (2015)

How I treat Langerhans cell histiocytosis

di Allen, Carl E., Ladisch, Stephan, McClain, Kenneth L.
Pubblicato in Blood (2015)

Langerhans-Cell Histiocytosis

di Allen, Carl E., Merad, Miriam, McClain, Kenneth L.
Pubblicato in N Engl J Med (2018)

Neither IL-17A mRNA Nor IL-17A Protein Are Detectable in Langerhans Cell Histiocytosis Lesions

di Peters, Tricia L, McClain, Kenneth L, Allen, Carl E
Pubblicazione 2011

Up-Front Therapy for LCH: Is It Time to Test an Alternative to Vinblastine/Prednisone?

di Simko, Stephen J., McClain, Kenneth L., Allen, Carl E.
Pubblicato in Br J Haematol (2014)

Clinical responses and persistent BRAF V600E(+) blood cells in children with LCH treated with MAPK pathway inhibition

di Eckstein, Olive S., Visser, Johannes, Rodriguez-Galindo, Carlos, Allen, Carl E.
Pubblicato in Blood (2019)

Cell(s) of Origin of LCH

di Collin, Matthew, Bigley, Venetia, McClain, Kenneth L, Allen, Carl E
Pubblicato in Hematol Oncol Clin North Am (2015)

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

di Ozuah, Nmazuo W., Lubega, Joseph, Allen, Carl E., El-Mallawany, Nader Kim
Pubblicato in Blood Adv (2020)

Transformation by Oncogenic Ras Expands the Early Genomic Response to Transforming Growth Factor β in Intestinal Epithelial Cells

di Allen, Carl E, Du, Jianguo, Jiang, Bo, Huang, Qin, Yakovich, Adam J, Barnard, John A
Pubblicazione 2008

How I treat hemophagocytic lymphohistiocytosis

di Jordan, Michael B., Allen, Carl E., Weitzman, Sheila, Filipovich, Alexandra H., McClain, Kenneth L.
Pubblicazione 2011

Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis

di Zinn, Daniel J, Eckstein, Olive, Olsen, Mary L, Allen, Carl E, McClain, Kenneth L
Pubblicato in Dermatol Case Rep (2019)

ZAS3 Accentuates Transforming Growth Factor β Signaling in Epithelial Cells

di Yakovich, Adam J., Jiang, Bo, Allen, Carl E, Du, Jianguo, Wu, Lai-Chu, Barnard, John A.
Pubblicazione 2010

Rate of Decline of Ferritin in Patients with Hemophagocytic Lymphohistiocytosis as a Prognostic Variable for Mortality

di Lin, Tiffany F., Ferlic-Stark, Laura L., Allen, Carl E., Kozinetz, Claudia A., McClain, Kenneth L.
Pubblicazione 2011